Strengths Acts via multiple pathways (GLP-1, AMPK, microbiome) Has existing human data showing reductions in fasting glucose, HbA1c, lipids Support receptor expression and islet health Limitations Low absorption and bioavailability Gastrointestinal discomfort is common (diarrhea, cramping)
Clinical evidence is increasingly demonstrating that GLP-1 receptor agonists provide cardiometabolic benefits beyond weight reduction
The Kowloon Walled City Park was officially opened on December 22, 1995, by the British Governor of Hong Kong, Chris Patten
A broad-spectrum SPF 30+ lip balm, applied every morning and reapplied through the day
PIONEER 3: Head-to-head vs Januvia (sitagliptin) 1,4 Study design: 78-week, randomized, double-blind, double-dummy, active controlled, parallel-group, phase 3a trial designed to assess the efficacy and assess long-term adverse event profile of once-daily semaglutide tablets vs Januvia in addition to metformin with or without sulfonylurea
Glucose consumption, lactate production, insulin secretion and total ATP content assays After pre-conditioning in the presence or absence of 50 nM Exendin-4 for 18 hours, BRIN-BD11 cells or isolated mouse islets were cultured in RPMI containing 20 mM of glucose in the absence of Exendin-4 for additional 24 hours